Linda Peters

Linda is a transformational leader with 30+ years of expertise in diagnostics, medtech, biotech, biopharma, and vaccines. She has driven the global development, approval, and commercialization of numerous healthcare products through her leadership in Regulatory Affairs, Quality, Compliance, and Public Policy. Currently, as SVP of Regulatory Affairs, Quality, and Clinical Compliance at GRAIL, Linda leads efforts to bring the Galleri multi-cancer early-detection blood test through FDA IVD Pre-Market Authorization. Previously, she was VP of Quality, Regulatory, Safety, and Trust at Google, shaping Google Health’s strategic healthcare vision, and EVP/Chief Regulatory Officer at BD, overseeing Regulatory and Government Affairs for a global medical device company. Linda has also held senior leadership roles at MedImmune/AstraZeneca, Baxter, and Takeda. An experienced board member, she serves on Airlife Medical’s board of directors. Linda holds an MBA from Northwestern University and MS/BS degrees in Animal Science/Biochemistry from Southern Illinois University.